StockWatch
·

TRANSPEK INDUSTRY LTD.-$

BSE: 506687

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
155.06
+1.7%-6.5%
Expenditure
143.27
-0.3%-1.2%
Net Profit
8.93
+35.7%-42.7%
OPM %
13.33%
+1.37pp-2.26pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.0048.9897.96146.94195.92Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Reports

Profit halved, growth stalled—the capex bet is now the story

Arclin concentration · capex execution · product pipeline risk

Result verdictFollow-upQ1 FY2725 Aug 20266 minMetals & Mining

Stalled growth, halved profit; restructuring play with R&D upside

product diversification · margin pressure · capacity constraints

TranscriptDeep diveQ1 FY2725 Aug 20266 minMetals & Mining

Transpek Q1 FY27: consolidated PAT falls 43% YoY to ₹8.93 Cr on margin compression

specialty chemicals · margin compression · profit decline

ResultsQ1 FY2707 Aug 20263 minMetals & Mining
Latest

Corporate Events

Board MeetingTRANSPEK
2026
15Sep

Board Meeting

The Annual General Meeting of the Company is scheduled to be…

BSE Filing ↗
Board MeetingTRANSPEK
2026
7Aug

Board Meeting

The meeting of the Board of Directors of the Company will be…

BSE Filing ↗
Board MeetingTRANSPEK
2026
26May

Board Meeting

The board meeting is scheduled to consider and approve the A…

BSE Filing ↗
Board MeetingTRANSPEK
2025
7May

Board Meeting

Consider and approve the Audited Standalone and Consolidated…

BSE Filing ↗
Board MeetingTRANSPEK
2024
13Nov

Board Meeting

consider and approve The Unaudited Financial

BSE Filing ↗
Board MeetingTRANSPEK
2024
21May

Board Meeting

Consider and approve Audited Financial Statements for the fo…

BSE Filing ↗
Board MeetingTRANSPEK
2024
12Feb

Board Meeting

Consider and approve Unaudited Financial Results for the qua…

BSE Filing ↗
Board MeetingTRANSPEK
2023
6Nov

Board Meeting

Consider and approve Unaudited Results for the quarter ended…

BSE Filing ↗